Namuh and ginkgo bioworks announce partnership to produce multiple infant nutrition products

Ginkgo will develop and optimize strains to produce functional oligosaccharides for namuh's infant nutrition products boston , jan. 18, 2023 /prnewswire/ -- namuh, an infant nutrition company, and ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk. namuh's mission is to create complete infant formula products substantially comparable to human breast milk, down to the molecular level.
DNA Ratings Summary
DNA Quant Ranking